Nova Cell Technology Overview

  • Founded
  • 2000
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $9.1M
Latest Deal Amount
  • Investors
  • 3

Nova Cell Technology General Information


Developer of biomaterials and pharmaceuticals intended to balance the immune system in a healthy way. The company's platform provides contract research services for new drug development as well as conducting collaborative research products with various other domestic and foreign universities, research labs, and institutions, enabling patients to cure diseases, such as atopy, asthma, dry eye disease, and inflammatory bowel disease .

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 77, Cheongam-ro, Nam-gu
  • Pohang University of Science and Technology
  • Pohang-si, Gyeongsangbuk-do
  • South Korea
+82 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nova Cell Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC $9.1M 000.00 Completed Generating Revenue
1. Early Stage VC 28-Sep-2020 00.000 00.000 Completed Generating Revenue
To view Nova Cell Technology’s complete valuation and funding history, request access »

Nova Cell Technology Executive Team (2)

Name Title Board Seat Contact Info
Taehoon Lee Ph.D Chief Executive Officer, Owner & President
Sunho Ki Ph.D Chief Technology Officer
To view Nova Cell Technology’s complete executive team members history, request access »

Nova Cell Technology Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AION Partners (New York) Real Estate Minority 000 0000 000000 0
Huons Global Corporation Minority 000 0000 000000 0
Korea Investment Partners Venture Capital Minority 000 0000 000000 0
To view Nova Cell Technology’s complete investors history, request access »